Study of BCX17725 for Netherton syndrome safety
Part of Genetic & congenital, Skin clinical trials.
This trial tests a new drug called BCX17725 in people with Netherton syndrome to see if it is safe and how the body handles it. It may help by reducing skin symptoms like redness and scaling.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 12 and 65 years old (depending on the part of the study).
- You must have a confirmed diagnosis of Netherton syndrome (for parts 3 and 4).
- Your skin symptoms must be moderate to severe, measured by a doctor’s rating (IGA score 3 or higher).
- You must not be pregnant or breastfeeding, and agree to use birth control during the study.
- Your kidney function must be normal for your age (checked with a blood test).
- You must be able to follow study rules and visit the clinic as needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new lotion (QRX003) designed to treat Netherton Syndrome, a rare genetic skin condition. The lotion is applied to affected skin areas to see if it can reduce symptoms and improve skin health.
This trial tests a prescription lotion (QRX003) to see if it is safe and helpful for people with Netherton syndrome. Because the study checks skin symptoms on certain body areas and closely controls other treatments, it may be best for patients who can keep their current regimen stable.
This trial tests a lotion called QRX003 for Netherton syndrome, a rare skin condition. It aims to see if the lotion is safe and helpful for managing symptoms.
This study looks at the bacteria on the skin and in the gut of people with Netherton syndrome, a condition that affects the skin barrier and often causes allergies. It also compares these findings to healthy volunteers to understand how the microbiome might be different.
This trial tests a new medication called BLX-0871 in healthy adults to see how safe it is and how the body processes it. If you are generally healthy and meet the age, weight, and lifestyle requirements, you may be able to join.
This Phase 1 study tests how a new medicine (TBN) behaves in the body after several doses, including side effects and tolerability. It is meant for healthy adults to help researchers decide how it can be used safely in future studies.
Hear when a new Netherton Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.